美国俄克拉荷马大学2024年招聘博士后（肿瘤学）

俄克拉荷马大学创建于1890年，是一所位于美国中南部俄克拉何马州的公立研究型大学。

俄克拉荷马大学在2021年度《美国新闻与世界报道》大学排名中位列全美第127名，世界第405位，根据CWUR世界大学排名2021年OU位列世界392名，卡内基高等院校分类标准指定的国家最高等级研究型大学。该校石油工程专业突出，在全美排第4位，是历史上第一个设立石油地质专业的高等院校。拥有全球最大的建于大学内的自然历史博物馆，其下属OUMC为全球顶尖医学院之一，在器官移植、神经外科学等领域均处于国际领先地位。OU会计学以及金融学研究成果优秀，根据杨百翰大学会计学研究排名（BYU Accounting Ranking），2021年该校累计在世界顶级会计学期刊发表论文的数量位列世界50名。学校坐落在俄克拉何马州的诺曼，距离俄克拉荷马城大都会区仅有30分钟的路程。该校毕业多名杰出校友，其中包括NBA球星特雷·杨，格里芬，新浪网CEO曹国伟；澳门特别行政区原特首崔世安；中国科学院“百人计划”入选者韦昌富。

NIH Funded Post-Doctoral Fellow, Associate Research Scholar

Employer

University of Oklahoma - Department of Oncology Science

Location

Oklahoma City, Oklahoma

Salary

Salary to be commensurate with experience

Closing date

Jan 2, 2025

NIH-funded post-doctoral research fellow position in pancreatic cancer metabolism

The Pankaj Singh lab at the newly established Department of Oncology Science and the NCI-designated OU Health Stephenson Cancer Center is recruiting a postdoctoral researcher to join on an NIH/NCI- funded study on pancreatic cancer metabolism. The research project involves investigating signal transduction and metabolic alterations in pancreatic cancer cells, tumor-stromal crosstalk, therapy resistance, metastasis, and immunometabolism, using cutting-edge technologies and multi-omics platforms. A successful postdoctoral candidate should have a Ph.D. in the relevant field with a strong theoretical background in basic biochemistry and molecular biology and/or human physiology. The candidate should be well versed with basic molecular biology and cell culture techniques. The project also involves utilizing cell line, organoid or mouse models of pancreatic cancer (PDX models and genetically engineered models). Some LC-MS/MS, bioinformatics, and small-animal research experience is preferred but not required. More details about our work can be found in some of our recent publications (Cancer Cell 2017 32(1):71-87; JEM 2020 217 (7):e20190745; Immunity 2019 50(3):576-590; Gastroenterology 2021 Jul 8:S0016-5085(21)03159-0; Nature Reviews Cancer 2023 Mar 27:1-20, PNAS 2024 Apr 2;121(14); Cancer Discovery 2024, 14(1):176-193; Elife 2024 Jul 8;12:RP87292; Nature Cell Biology 2024 Apr;26(4):613-627).

Our state-of-the art research program utilizes multi-omics approaches, including metabolomics, spatial metabolomics, sc-RNA-seq, epigenomics, and proteomics. Our program is well-funded by NCI, with multiple R01 grants and U54 grant on acquired therapy resistance in pancreatic cancer.

The Singh lab is a friendly and welcoming place with great excitement for cancer research. We plan to complete the recruitment process soon.

Interested candidates should submit their CV directly at Onc-Sci@ouhsc.edu.

The University of Oklahoma Health Sciences Center seeks to recruit and retain a diverse community of health professionals and scholars. We seek a community with a wide range of perspectives and experiences, and we provide equal employment opportunities to qualified applicants without regard to race, color, religion, political beliefs, national origin, age (40 or older), sex (see: Sexual Misconduct, Discrimination policy) sexual orientation, genetic information, gender identity, gender expression, disability, or veteran status.